Everything you need to win Cue Biopharma — in one platform.
Who to reach, what to say, and why now on Cue Biopharma — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Cue Biopharma — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
CUE Biopharma Appoints Lucinda Warren As Chief Business Officer
PUBLIC · CUESep 09, 2024•almost 2 years ago
Company
Cue Biopharma
BostonBiotechnologyHealth CareTherapeutics
Description
Cue Biopharma, Inc. has appointed Lucinda Warren as chief business officer (CBO). With extensive experience in strategic transactions, portfolio optimization, and alliance management, Lucinda Warren will play a pivotal role in advancing Cue Biopharma’s core corporate objectives following the company’s recent business restructuring and autoimmune program prioritization.
Company Information
Company
Cue Biopharma
Location
Boston, Massachusetts, United States
About
Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease. Cue Biopharma’s proprietary platform, Immuno-STAT® (Selective Targeting and Alteration of T Cells) and biologics are designed to harness the curative potential of the body’s innate immune system through the selective modulation of disease-relevant T cells without the adverse effects of broad systemic immune activation.
BostonBiotechnologyHealth CareTherapeutics